Le Lézard
Classified in: Covid-19 virus
Subject: Lawsuit

Lieff Cabraser and Equal Justice Society File Class Action Challenging Trump Administration's Alleged Theft of Congressionally-Allocated Pandemic Relief Funds from Incarcerated Persons and the Families They Support


Today, Lieff Cabraser Heimann & Bernstein, LLP and Equal Justice Society (collectively, "Plaintiffs' co-counsel") filed a class action lawsuit in federal court in San Francisco, California, challenging the Internal Revenue Service and Department of Treasury (collectively "Treasury")'s decision to withhold CARES Act economic assistance payments from incarcerated people nationwide. The lead plaintiffs are Colin Scholl, currently incarcerated in Salinas Valley State Prison in Monterey, California, and Lisa Strawn, a woman paroled from San Quentin on July 14, 2020. Plaintiffs and the proposed class seek a determination that Defendants' conduct is illegal and an Order that they make the required payments immediately.

Background: Congress passed the CARES Act to provide sorely needed economic assistance during the economic crisis triggered by the COVID-19 pandemic. Under the Act, Congress allocated aid of up to $1,200 (plus $500 per qualifying child) to all American citizens and legal permanent residents below a certain income level who were not claimed as dependents. Incarcerated persons, and their families on the outside, are among the most economically disadvantaged people in the country. Indeed, according to one study, people who are incarcerated had a median income of only $19,185 before their incarceration, compared to $41,250 for non-incarcerated people. Low-income families are disproportionately more likely to have a relative behind bars.

The Treasury, however, has refused to issue stimulus payments authorized by Congress to eligible incarcerated persons, thereby further exacerbating the economic disadvantages they and their families suffer.

"The Treasury Department's unlawful withholding of these allocated funds undermines the health and safety of incarcerated people and the families they support," said Kelly M. Dermody of Lieff Cabraser Heimann & Bernstein, LLP, an attorney representing the plaintiffs in the case. "At a time when COVID-19 is tearing through prisons, it is unforgivably heartless to steal COVID economic aid from those most in need."

The populations that COVID-19 has decimated?low-income children of color, Black people, Latinx people and other people of color?are also disproportionately impacted by over-incarceration," said Mona Tawatao of the Equal Justice Society, an attorney for the plaintiffs. "The Treasury Department's theft of CARES Act supplements is both illegal and cruel as it subverts Congress' plan to provide fast and direct economic assistance to families who need help the most."

The lawsuit alleges that over 1.4 million incarcerated people have been affected by Defendants' actions. Many rely on financial assistance from their friends or families on the outside, people who are already suffering in the current economic crisis. Hundreds of thousands of others will be re-entering society soon, and need help to get back on their feet at a time when the job market has collapsed. Incarcerated people also need to spend their own money?or that of friends and family who are already hard-pressed to make ends meet?to stay in touch with loved ones through expensive telephone and mail services, critical lifelines to support their rehabilitation. Further, many incarcerated people have outstanding child support and restitution obligations, and stimulus payments can be used to support children in need as well as crime victims.

The plaintiffs are Colin Scholl and Lisa Strawn. The Lieff Cabraser legal team representing them and the proposed class are Kelly M. Dermody, Yaman Salahi, and Jalle H. Dafa, joined by Eva Jefferson Paterson, Mona Tawatao, Lisa Holder, and Christina Alvernaz of the Equal Justice Society.

The defendants are the Treasury Secretary Steven Mnuchin, the United States Commissioner of Internal Revenue Charles Rettig, the U.S. Department of the Treasury, the U.S. Internal Revenue Service, and the United States of America.

Read the complaint here. If you or your loved one is an incarcerated person, please click here for a free legal consultation about your rights.

More about Lieff Cabraser Heimann & Bernstein, LLP:

Lieff Cabraser Heimann & Bernstein, LLP, is a 100-plus attorney AV-rated law firm founded in 1972 with offices in San Francisco, New York, Nashville, and Munich. Described by The American Lawyer as "one of the nation's premier plaintiffs' firms," Lieff Cabraser has litigated some of the most important civil cases in the United States and assisted clients in recovering over $124 billion in verdicts and settlements. In March of 2020, Benchmark Litigation named Lieff Cabraser its "California Plaintiff Firm of the Year." Lieff Cabraser is committed to access to justice for all.

The Equal Justice Society is transforming the nation's consciousness on race through law, social science, and the arts. Led by President Eva Paterson, its legal strategy aims to broaden conceptions of present-day discrimination to include unconscious and structural bias by using social science, structural analysis, and real-life experience. Currently, EJS targets its advocacy efforts on school discipline, special education, and the school-to-prison pipeline, race-conscious remedies, and inequities in the criminal justice system.


These press releases may also interest you

at 03:05
Vagaro, the leading international salon and spa software, and Jack Mead, award-winning hair stylist, salon owner, and educator, officially announced the release of their highly-anticipated Master Class series, delivering expert insights on using the...

at 02:30
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:05
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2024. "All outstanding major construction at our QB operation was completed in the first quarter, including the shiploader and molybdenum plant, and we marked the...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...



News published on and distributed by: